| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |